- •1. Introduction
- •1.1 Classification
- •1.2 References
- •2.2 Background
- •2.3 Definition
- •2.4 Aetiological spectrum
- •2.5 Acute uncomplicated cystitis in pre-menopausal, non-pregnant women
- •2.8 UtIs in pregnancy
- •2.9 UtIs in post-menopausal women
- •2.11 References
- •19. Roberts fj.
- •27. Sanford jp.
- •28. Kinane df, Blackwell cc, Brettle rp, Weir dm, Winstanley fp, Eltor ra.
- •32. Nicolle le, Harding gkm, Preiksaitis j, Ronald ar.
- •50. Wadland wc, Planten da.
- •60. Vorland lh, Carlson k, Aalen odd.
- •3.2 Background
- •3.3 Aetiology
- •3.4 Pathogenesis
- •3.5 Signs and symptoms
- •3.7 Schedule of investigation
- •If findings indicate pathology
- •3.9 References
- •21. Jantausch pa, Rifai n, Getson p, Akrem s, Majd m, Wiedermann bl.
- •32. Rushton hg, Majd m, Jantausch b, Wiedermann l, Belman ab.
- •43. Kleinman pk, Diamond ba, Karellas a, Spevak mr, Nimkin k, Belenguer p.
- •4.2 Background
- •4.3 What are the acute effects of a uti on the kidney and do the lesions become chronic? Can they be prevented?
- •4.7 References
- •5.2 Definitions and classification
- •5.4 Treatment
- •5.5 Conclusions
- •5.6 References
- •6.2 Background
- •6.3 Definition and clinical manifestation of sepsis syndrome in urology
- •6.4 Physiology and biochemical markers
- •6.5 Prevention
- •6.6 Treatment of underlying disease
- •6.7 Conclusion
- •6.8 References
- •7.7 Therapy
- •7.8 Prevention
- •8.2 Prostatitis
- •8.3 Epididymitis and orchitis
- •8.4 References
- •1. Meares em, Stamey та.
- •2. Weidner w, Schiefer hg, Krauss h, Jantos Ch, Friedrich hj, Altmannsberger m.
- •3. Schaeffer aj.
- •8. Alexander rb, Ponniah s, Hasday j, Hebel jr.
- •26. Barbalias ga, Nikiforidis g, Liatsikos en.
- •27. Mayersak js.
- •28. Jimenez Cruz jf, Boronat f, Gallego j.
- •33. Naber kg, Weidner w.
- •9. Peri-operative antibacterial prophylaxis in urology
- •9.1 Summary
- •9.2 Introduction
- •9.3 Goals of peri-operative antibacterial prophylaxis
- •9.4 Indications for peri-operative antibacterial prophylaxis
- •9.5 Timing and duration of peri-operative antibacterial prophylaxis
- •9.6 Choice of antibiotics
- •9.7 Mode of application
- •9.8 Recommendations according to type of urological intervention
- •9.10 References
- •1. Rubin rh, Shapiro ed, Andriol vt, Davies rj, Stamm we.
- •3. Naber kg.
- •3. Recommendations for peri-operative antibacterial prophylaxis in urology (modified according to ref 1)
- •4. Antibacterial agents
- •4.1 Penicillins
- •4.2 Parenteral cephalosporins
- •4.3 Oral cephalosporins
- •4.4 Monobactams
- •4.5 Carbapenems
- •4.6 Fluoroquinolones
- •4.7 Macrolides
- •4.8 Tetracyclines
- •4.9 Aminoglycosides
- •4.10 Glycopeptides
- •4.11 References
4.11 References
1. Scholz H, Naber KG, and an expert group of the Paul Ehrlich Society for Chemotherapy.
Einteilung der Oralcephalosporine. Chemotherapie Journal 1999; 8: 227-229.
2. Vogel F, Naber KG, Wacha H, Shah P, Sorgel F, Kayser FH, Maschmeyer G, Lode H, and an expert group of the Paul Ehrlich Society for Chemotherapy.
Parenterale Antibiotika bei Erwachsenen. Chemotherapie Journal 1999; 8: 3-49.
3. Naber KG, Adam D, and an expert group of the Paul Ehrlich Society for Chemotherapy.
Einteilung der Fluorchinolone. Chemotherapie Journal 1998; 7: 66-68.
4. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE.
Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999; 29: 745-758.
ABBREVIATIONS USED IN THE TEXT
ABP: acute bacterial prostatitis
APCKD: adult polycystic kidney disease
AUA: American Urological Association
B. fragilis: Bacteriodes fragilis
BLI: P-lactamase inhibitor
BPH: benign prostatic hyperplasia
СВР: chronic bacterial prostatitis
Cfu: colony-forming unit
CPPS: chronic pelvic pain syndrome
CRP: C-reactive protein
CT: computed tomography
С trachomatis: Chlamydia trachomatis
DMSA: dimercaptosuccinic acid
E. coli: Escherichia coli
ESCMID: European Society of Clinical Microbiology and Infectious Diseases
EPS: expressed prostatic secretion
ESWL: extracorporeal Shockwave lithotripsy
G-CSF: granulocyte-colony stimulating factor
GM-CSF: granulocyte-macrophage-colony stimulating factor
HCO: Health Care Office of the EAU
H. influenzae: Haemophilus influenzae
IDSA: Infectious Diseases Society of America
Ig: immunoglobulin
IL: interleukin
LUTS: lower urinary tract symptoms
M. catarrhalis: Moraxella catarrhalis
MRSA: methicillin-resistant Staphylococcus aureus
MRSE: methicillin-resistant coagulase negative staphylococci
MSU: mid-stream sample of urine
M. tuberculosis: Mycobacterium tuberculosis
N. gonorrhoeae: Neisseria gonorrhoeae
NIDDK: National Institute of Diabetes, Digestive and Kidney Diseases
NIH: National Institutes of Health
PaCCh: partial pressure of carbon dioxide in alveolar gas
P. aeruginosa: Pseudomonas aeruginosa
P. mirabilis: Proteus mirabilis
PSA: prostate-specific antigen
S. aureus: Staphylococcus aureus
S. saprophyticus: Staphylococcus saprophyticus
Tc: technetium
TMP: trimethoprim
TNF: tumour necrosis factor
TURP: transurethral resection of the prostate
T. vaginalis: Trichomonas vaginalis
SIRS: systemic inflammatory response syndrome
SMX: sulphamethoxazole
STD: sexually transmitted disease
UTI: urinary tract infection(s)
VB1: first-voided urine
VB2: mid-stream urine
VB3: voided bladder urine-3
VCU: voiding cysto-urethography
VUR: vesico-ureteric reflux
WBC: white blood cells
WHO: World Health Organisation